trivago N.V. (NASDAQ:TRVG)
trivago N.V. is a technology company. It provides internet-related services and products in the fields of hotels, lodging and metasearch. trivago N.V. is based in Duesseldorf, Germany.
trivago N.V. (NASDAQ:TRVG)’s Financial Overview
trivago N.V. (NASDAQ) surged 2.6% yesterday to close its trading session at $6.31. The company has 1 year Price Target of $5.74. trivago N.V. has 52-Week high of $10.05 and 52-Week Low of $4.01. The stock touched its 52-Week High on 10.05 and 52-Week Low on 4.01. The stock traded with the volume of 195364 shares yesterday. The firm shows the market capitalization of $2.15 Billion.
trivago N.V. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.03/share against the analyst consensus estimate of $-0.01/share. The difference between the actual and expected EPS is $0.04 a share with a surprise factor of 400%.
The firm is trading with SMA20 of 6.99 Percent, SMA50 of 1.35 Percent and SMA200 of 17.93 percent. trivago N.V. has P/S value of 2.01 while its P/B value stands at 2.3. Similarly, the company has Return on Assets of -3.9 percent, Return on Equity of -5 percent and Return on Investment of -1.6 Percent. The company shows Gross Margin and Operating Margin of 99.4 percent and -5.5 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 12 analysts offering 12-month price forecasts for Trivago NV have a median target of 5.73, with a high estimate of 6.50 and a low estimate of 4.50. The median estimate represents a -9.27% decrease from the last price of 6.31.
trivago N.V. is estimated to report earnings on 02/06/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 8 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.01. The reported EPS for the same quarter last year was $-0.03.
Avid Bioservices, Inc. (NASDAQ:CDMO)
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.
Avid Bioservices, Inc. (NASDAQ:CDMO)’s Financial Outlook
The 3 analysts offering 12-month price forecasts for Avid Bioservices Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +117.39% increase from the last price of 4.60.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
According to Zacks Investment Research, Avid Bioservices, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined -1.71% and closed its last trading session at $4.6. The company has the market capitalization of $262.38 Million. The stock has 52-week high of $8.44 and 52-Week low of $2.24. The firm touched its 52-Week high on 8.44 and 52-Week low on 2.24. The company has volume of 151259 shares. The company has a total of 57.04 Million shares outstanding.
Avid Bioservices, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.05/share where the analyst estimated EPS was $-0.08/share. The difference between the actual and Estimated EPS is $0.03. This shows a surprise factor of 37.5 percent.
The company has YTD performance of 12.2 percent. Beta for Avid Bioservices, Inc. stands at 2.92 while its ATR (average true range) is 0.32. The company has Weekly Volatility of 6.21%% and Monthly Volatility of 7.46%%.
Avid Bioservices, Inc. has distance from 20-day Simple Moving Average (SMA20) of 0.65%, Distance from 50-Day Simple Moving Average of -6.24 percent and Distance from 200-Day Simple Moving Average of -4.57%.
The Company currently has ROA (Return on Assets) of -19.9 percent, Return on Equity (ROE) of -33.1 Percent and Return on Investment (ROI) of -37.1% with Gross margin of -12.5 percent and Operating & Profit margin of -53.7% and -45% respectively.